Buch, Englisch, 444 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 1070 g
Buch, Englisch, 444 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 1070 g
ISBN: 978-0-12-800226-1
Verlag: William Andrew Publishing
Recent discoveries in epigenetic research enabled by epic advances in genomic technologies have positioned the field for broad translation to therapeutic interventions for previously unmanageable disorders Neuropsychiatric disorders represent a prime target of epigenetic interventions as they are highly debilitating, often chronic diseases with enormous costs to society. Thus, this volume will help define epigenetics as a key player in neuropsychiatric disorders, highlighting the full spectrum of epigenetic mechanisms underlying such disorders and introducing the vast range of epigenetic therapies under development.
Zielgruppe
<p>Graduate level doctoral students, medical students, clinicians, academic scientists, policy makers and applied scientists are the target audience for this volume. The work should appeal to those involved in genetic, biochemical, neuroscience, molecular biologic, pharmaceutical and psychiatric research.</p>
Autoren/Hrsg.
Fachgebiete
- Sozialwissenschaften Psychologie Allgemeine Psychologie Biologische Psychologie, Neuropsychologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
Weitere Infos & Material
Preface Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson
Section I. Neuropsychiatric Disorders and Epigenetics: General Aspects 1. Introduction to Neuropsychiatric Disorders and Epigenetics Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson
2. Environmental Factors and Epigenetics of Neuropsychiatric Disorders Anke Hoffmann and Dietmar Spengler
3. Epigenetic Biomarkers in Neuropsychiatric Disorders Chin-Chuen Lin, Tiao-Lai Huang
Section II: Epigenetics of Neuropsychiatric Disorders 4. Epigenetics and Cognitive Disorders -Translational Aspects Fabio Coppedè
5. Epigenetics in Pervasive Developmental Disorders - Translational Aspects Takeo Kubota
6. Epigenetic causes of intellectual disability - the fragile X syndrome paradigm Elisabetta Tabolacci, Giovanni Neri
7. Epigenetics of Attention-Deficit Hyperactivity Disorder Nader Perroud, Sébastien Weibel, Jean-Michel Aubry, Alexandre Dayer
8. The epigenetics of brain aging and psychiatric disorders Huan Gong, Xiangru Xu
9. Epigenetic therapy may alleviate cognitive deficits in Down syndrome by downregulating overexpressed chromosome 21 gene products Alain D. Dekker, Peter P. De Deyn and Marianne G. Rots
10. Epigenetics and Multiple Sclerosis Lara Kular, Gonçalo Castelo-Branco and Maja Jagodic
11. Epigenetics and Migraine Siew Hua Gan and Munvar Miya Shaik
12. The role of epigenetics in the pathophysiology of epilepsy Sung Min Nam and Kyung-Ok Cho
13. Epigenetic Dysregulation in Brain Tumors and Neurodevelopment Marco M. Hefti and Nadejda Tsankova
14. Epigenetics and Cerebrovascular Diseases Carolina Soriano-Tárraga, Jordi Jiménez-Conde and Jaume Roquer
15. Epigenetics and Eating Disorders Helge Frieling, Vanessa Buchholz
16. Epigenetics in Obesity Brian M. Shewchuk
17. Epigenetics and Drug Addiction-Translational Aspects Jian Feng
18. Epigenetics and Alcohol Use Disorders Sneha Sagarkar and Amul Sakharkar
Section III: Summary and Outlook 19. Summary and Outlook Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson